These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
732 related articles for article (PubMed ID: 19158789)
1. The promises and pitfalls of RNA-interference-based therapeutics. Castanotto D; Rossi JJ Nature; 2009 Jan; 457(7228):426-33. PubMed ID: 19158789 [TBL] [Abstract][Full Text] [Related]
2. RNA interference in three humans. Hare P Nat Biotechnol; 2010 Apr; 28(4):335. PubMed ID: 20379178 [No Abstract] [Full Text] [Related]
3. Interfering with disease: opportunities and roadblocks to harnessing RNA interference. Lieberman J; Song E; Lee SK; Shankar P Trends Mol Med; 2003 Sep; 9(9):397-403. PubMed ID: 13129706 [TBL] [Abstract][Full Text] [Related]
4. RNAi mechanisms and applications. Kim D; Rossi J Biotechniques; 2008 Apr; 44(5):613-6. PubMed ID: 18474035 [TBL] [Abstract][Full Text] [Related]
5. Companies in footrace to deliver RNAi. Bouchie A Nat Biotechnol; 2012 Dec; 30(12):1154-7. PubMed ID: 23222766 [No Abstract] [Full Text] [Related]
6. RNA interference: an emerging generation of biologicals. Shrivastava N; Srivastava A Biotechnol J; 2008 Mar; 3(3):339-53. PubMed ID: 18320564 [TBL] [Abstract][Full Text] [Related]
7. Silencing of disease-related genes by small interfering RNAs. Fuchs U; Damm-Welk C; Borkhardt A Curr Mol Med; 2004 Aug; 4(5):507-17. PubMed ID: 15267222 [TBL] [Abstract][Full Text] [Related]
8. Innovations in siRNA research: a technology comes of age. Hefferon KL Recent Pat Antiinfect Drug Discov; 2010 Nov; 5(3):226-39. PubMed ID: 20812899 [TBL] [Abstract][Full Text] [Related]
9. Harnessing RNA interference to develop neonatal therapies: from Nobel Prize winning discovery to proof of concept clinical trials. DeVincenzo JP Early Hum Dev; 2009 Oct; 85(10 Suppl):S31-5. PubMed ID: 19833462 [TBL] [Abstract][Full Text] [Related]
10. Small-interfering RNAs (siRNAs) as a promising tool for ocular therapy. Guzman-Aranguez A; Loma P; Pintor J Br J Pharmacol; 2013 Oct; 170(4):730-47. PubMed ID: 23937539 [TBL] [Abstract][Full Text] [Related]
11. Journey of siRNA: Clinical Developments and Targeted Delivery. Nikam RR; Gore KR Nucleic Acid Ther; 2018 Aug; 28(4):209-224. PubMed ID: 29584585 [TBL] [Abstract][Full Text] [Related]
12. Cutaneous short-interfering RNA therapy. Geusens B; Sanders N; Prow T; Van Gele M; Lambert J Expert Opin Drug Deliv; 2009 Dec; 6(12):1333-49. PubMed ID: 19941411 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic potentials of gene silencing by RNA interference: principles, challenges, and new strategies. Deng Y; Wang CC; Choy KW; Du Q; Chen J; Wang Q; Li L; Chung TK; Tang T Gene; 2014 Apr; 538(2):217-27. PubMed ID: 24406620 [TBL] [Abstract][Full Text] [Related]
15. Cardiovascular RNA interference therapy: the broadening tool and target spectrum. Poller W; Tank J; Skurk C; Gast M Circ Res; 2013 Aug; 113(5):588-602. PubMed ID: 23948584 [TBL] [Abstract][Full Text] [Related]
16. RNA-interference-based gene therapy approaches to HIV type-1 treatment: tackling the hurdles from bench to bedside. von Eije KJ; Berkhout B Antivir Chem Chemother; 2009; 19(6):221-33. PubMed ID: 19641231 [TBL] [Abstract][Full Text] [Related]
17. RNA interference as a gene knockdown technique. Shan G Int J Biochem Cell Biol; 2010 Aug; 42(8):1243-51. PubMed ID: 19442757 [TBL] [Abstract][Full Text] [Related]
18. RNA interference: Homing in on delivery. Baker M Nature; 2010 Apr; 464(7292):1225-8. PubMed ID: 20414308 [No Abstract] [Full Text] [Related]
19. Leading RNA Interference Therapeutics Part 1: Silencing Hereditary Transthyretin Amyloidosis, with a Focus on Patisiran. Titze-de-Almeida SS; Brandão PRP; Faber I; Titze-de-Almeida R Mol Diagn Ther; 2020 Feb; 24(1):49-59. PubMed ID: 31701435 [TBL] [Abstract][Full Text] [Related]
20. RNA interference in mammalian cell systems. Lochmatter D; Mullis PE Horm Res Paediatr; 2011; 75(1):63-9. PubMed ID: 21252559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]